You are here

ACH-3422

Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results

TheStreet.com

Mon, 12/22/14 - 01:14 pm

Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)

Yahoo/Globe NewsWire

Sat, 11/8/14 - 10:39 am

Achillion presents preclinical profile of HCV drug candidate

Yahoo/Fly on the Wall

Mon, 11/4/13 - 09:19 am